Roche Unveils Newborn Screening Test For 3 Genetic Conditions Of SMA, SCID, Sickle Cell Disease

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW) announced Wednesday the launch of newborn screening test for three severe genetic conditions, such as Spinal Muscular Atrophy or SMA, Severe Combined Immunodeficiency Disease or SCID, and Sickle Cell Disease or